2020-2027 Analysis and Review Albendazole Market

Albendazole Market

Albendazole Market By Clinical Application (Soil-transmitted Helminths, Schistosomiasis and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

17-05-2020 REP-HC-5088 40 Tables 110 pages Format

The albendazole market was valued at USD 588.0 Mn by 2019. A significant increase in the soil-transmitted helminths infection worldwide primarily drives the albendazole market growth. Furthermore, effective implementation of treatment guidelines pertaining to parasitic infection by healthcare agencies throughout the globe further accentuates the albendazole market growth.

Albendazole Market

Albendazole is considered a broad-spectrum anthelmintic drug that exerts its pharmacological activity by inhibiting tubulin polymerization which eventually causes the loss of cytoplasmic tubulin. This phenomenon causes the depletion of the glycogen stores of the parasites which is critical for its survival. Albendazole is enlisted in the World Health Organization (WHO), list of essential medicines. It needs to be taken under medical supervision as an overdose in children might result in fatal outcomes.

The major segments related to the albendazole market are: 

By Clinical Application (2017–2027; US$ Mn)

Soil-transmitted Helminths

Schistosomiasis

Others

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global albendazole market
  • The overall segmentation of the albendazole market, by clinical application, distribution channel, and geography is minutely studied. Soil-transmitted helminths and hospital pharmacy are dominating the clinical application and distribution channel segments respectively
  • Rising prevalence of helminthic infections throughout the globe
  • Constant rise in the schistosomiasis infection in the developing regions due to rapid industrialization further accentuate the albendazole market growth

Report gist?

  • The study of the global albendazole market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical manufacturers actively engaged in the production and marketing of albendazole due to the  rising prevalence of helminthic infections worldwide
  • The report will benefit formulation scientist engaged in the development of albendazole drug formulation to yield better therapeutic efficacy
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to albendazole market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

In the present scenario the soil-transmitted helminths infection is dominating the clinical application segment for the albendazole market. According to the latest research citings presented by the Center for Disease Control and Prevention (CDC), soil-transmitted helminths infection also called neglected tropical disease usually occurs in the warm & moist climate where there are poor civic amenities and hygiene. The Ascaris infection is reported in approximately 807-1,121 million people, whipworm is reported in 604-795 million and hookworm is reported in 576-740 million people worldwide. Schistosomiasis is expected to register rampant market growth during the forecast period. Rapid industrialization in the developing countries has resulted in tremendous water pollution which provides potent breeding grounds for schistosomiasis pathogens. According to the latest research citings provided by the World Health Organization (WHO), approximately 290.8 million people worldwide received treatment for schistosomiasis in 2018.

Hospital pharmacy is currently spearheading the distribution channel segment for the albendazole market. Overdose associated with albendazole has fatal effects among children population suffering from helminthic infections, hence it is mandatory for the hospital pharmacist to precisely compound the albendazole drug formulation in accordance with a physician’s prescription. Retail pharmacy has gained tremendous traction in the last 2 decades in the developing regions owing to the flourishing generic drugs market and the ability to provide medicines at affordable prices.

Asia Pacific is presently leading the geography segment for the albendazole market. Rising prevalence of soil-transmitted helminths infection primarily drives the albendazole market growth in the region. The tropical climate prevalent in the South East Asian countries provides a teeming growing for the spread of neglected tropical diseases. Domicile of key players in the region such as Cadila Healthcare Limited, Cipla Limited., GlaxoSmithKline, Plc., Dr. Reddys Laboratories Ltd., etc further accentuate the albendazole market growth in the region. Latin America is the second-largest regional segment in the albendazole market. The rising prevalence of schistosomiasis infection in the rainforest region determines the albendazole market growth in the region. North America is anticipated to register the fastest market growth in the regional segment for the albendazole market. South-Eastern region of the United States shows few cases of helminthic infections, however effective implementation of the treatment guidelines pertaining to parasitic infection drives the demand for albendazole market growth in the North American region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.